Stockreport

Why Xeris Biopharma Holdings (XERS) Is Up 7.9% After Raising 2025 Revenue Outlook and Adding Patents [Yahoo! Finance]

Xeris Biopharma Holdings, Inc.  (XERS) 
Last xeris biopharma holdings, inc. earnings: 3/11 06:00 am Check Earnings Report
PDF guidance range and highlighting stronger-than-expected demand for Recorlev and Gvoke. Alongside the revenue upgrade, the company bolstered its intellectual property po [Read more]